治疗格拉姆阴性细菌感染的知识的演变
Almudena Burillo1,2,3, Emilio Bouza1,2,3,4
1Department of Clinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañón.
Current opinion in infectious diseases
|September 11, 2024
概括
由于现代医学的进步,阴性细菌 (GNB) 感染正在增加. 新的抗微生物策略和诊断对于对抗这些具有挑战性的感染至关重要.
科学领域:
- 微生物学 微生物学
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 自20世纪中叶以来,格拉姆阴性细菌 (GNB) 感染显著增加,特别是随着免疫缺陷和抗生素使用的增加.
- 导致这种增长的因素包括抗癌治疗,手术,皮质类固醇使用和假肢材料的进步,以及更好地控制阳性感染.
- GNB具有独特的双膜,需要特定的抗菌剂能够穿透它进行有效的治疗.
研究的目的:
- 审查Gram-阴性细菌 (GNB) 感染的不断变化的景观.
- 分析GNB的历史和当前的抗菌治疗方法.
- 讨论应对GNB感染的挑战和未来方向.
主要方法:
- 关于格拉姆阴性细菌 (GNB) 感染和抗菌药物治疗的研究文献综述.
- 对各种抗生素类对GNB的历史疗效和局限性的分析.
- 探索新兴的治疗策略和诊断方面的进展.
主要成果:
- 早期的抗生素,如硫胺和青素G,对GNB的疗效有限.
- 包括安培在内的β-乳类药物扩大了治疗选择,但日益增长的耐药性需要探索替代方案.
- 氨基糖化物,聚米辛,四环素和诺基诺是当前的选择,通常需要对难以到达的部位进行组合治疗.
- 正在研究新的方法,如菌体治疗与抗生素相结合.
结论:
- 未来的策略必须包括更窄谱的免疫抑制剂和保护人类微生物群的抗生素.
- 快速诊断方法对于及时和有针对性的GNB感染管理至关重要.
- 需要转向更精确,更少破坏性的抗微生物干预措施,以减少GNB在传染病理中的流行率.
相关概念视频
Combined Effects of Drugs: Synergism
3.8K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.8K
Antibiotic Selection
52.4K
Overview
52.4K
Genomic DNA in Prokaryotes
43.6K
The genome of most prokaryotic organisms consists of double-stranded DNA organized into one circular chromosome in a region of cytoplasm called the nucleoid. The chromosome is tightly wound, or supercoiled, for efficient storage. Prokaryotes also contain other circular pieces of DNA called plasmids. These plasmids are smaller than the chromosome and often carry genes that confer adaptive functions, such as antibiotic resistance.
Genomic Diversity in Bacteria
Although bacterial genomes are much...
Genomic Diversity in Bacteria
Although bacterial genomes are much...
43.6K
Defense Against Bacterial Pathogens
1.4K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.4K
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
333
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
333
Pneumonia IV: Management
309
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
309


